The medication class of thiazolidinedione (also called glitazones) was introduced in the late 1990s as an adjunctive It is being investigated experimentally in polycystic ovary syndrome (PCOS), non-alcoholic steatohepatitis (NASH),[2] psoriasis,[3] autism,[4] and other conditions.therapy for diabetes mellitus (type 2) and related diseases.

Thiazolidine 2,4 dione